ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
PARP inhibitors could exploit weaknesses in a range of cancers pharmatimes
April 26, 2021PARP inhibitors – a type of drug most commonly used to treat ovarian and breast cancers – could offer a new way of targeting a range of cancers with a particular gene defect in the PBRM1 gene, according to researchers.
Pharma Sources Insight July 2025
